title: [Pharmacogenetic analysis can predict adverse effects of statins].
authors.affiliation: Klinisk kemi och farmakologi, Akademiska sjukhuset, Uppsala. daniel.garwicz@medsci.uu.se
authors.forename: Daniel
authors.initials: D
authors.lastname: Garwicz
authors.forename: Mia
authors.initials: M
authors.lastname: Wadelius
mesh_terms: D060005:Genotyping Techniques; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D027381:Liver-Specific Organic Anion Transporter 1; D009135:Muscular Diseases / Q000139:chemically induced / Q000235:genetics; D027361:Organic Anion Transporters / Q000235:genetics*; D018570:Risk Assessment; D012307:Risk Factors; D019821:Simvastatin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D027381:Liver-Specific Organic Anion Transporter 1; D027361:Organic Anion Transporters; C503999:SLCO1B1 protein, human; D019821:Simvastatin